Resources

Will U.S. Doctors Prescribe Biosimilars?
By Charu Gupta

A new InCrowd MicroSyndicated Survey Report looks at what 150 physicians across multiple specialty areas commonly requiring prescription of biologics think about the coming market in biosimilars.

Our survey, administered using our real-time microsurvey technology platform, probes the intersections between market evolution and patient needs. See our infographic below for a summary of some of the key findings, and please contact us at syndicated@incrowdnow.com to get a complimentary copy of the full report that includes doctor perspectives by specialty area.

 

 

Related Resources

Reframing Mental Health Awareness Month

Reframing Mental Health Awareness Month

Happy Mental Health Awareness Month! But wait… is it really happy? What does mental health awareness truly mean? I’ve always struggled with the idea of dedicating a single month to a specific cause. While it’s important to de-stigmatize mental illness and endeavor to...

read more
Employee Spotlight: Marisa Meyers

Employee Spotlight: Marisa Meyers

Marisa Meyers is the Director of Digital Marketing at Apollo Intelligence, learn more about her below! Tell us about your role. As the Director of Digital Marketing, I design, implement, and measure digital marketing strategies for Apollo and its commercial brands,...

read more